Valley prostate cancer survivor urges early detection

A San Benito man who survived prostate cancer is urging men to get physical exams for the disease because blood and urine tests sometimes come negative.

CytRx commences PROACT Phase 2 clinical trial of bafetinib for advanced prostate cancer

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced initiation of the PROstate Advanced Cancer Treatment (PROACT) Phase 2 proof-of-concept clinical trial to evaluate the efficacy and safety of bafetinib in patients with advanced prostate cancer.

National study proves illness prevention programs save lives & give best value for money

University of Queensland and Deakin University researchers have today released a report with dozens of recommendations that strongly support more spending on prevention, but also warn that not all prevention measures are wise investments.

Call for preventative health overhaul

A report on preventative health has outlined a reform agenda that could "prevent a million premature deaths" in Australia.

Call to subsidise heart pill for 1.3m patients

A POLYPILL that combines three drugs to lower blood pressure and cholesterol should be subsidised for all Australians with more than 5 per cent risk of a heart attack or stroke within five years, experts have recommended in a new report.